DENVER--(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that the California Medical ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
Photo courtesy of starline on Freepik. Opinions expressed by Digital Journal contributors are their own. Santosh Kesarpu has established expertise in complex generic formulation, applying rigorous ...
Austin’s Evolving CBD Market: Minor Cannabinoids, Raw Extraction & Science-Driven Formulations True Hemp Science A shift toward science-backed products has created new opportunities for ...
DENVER--(BUSINESS WIRE)--GALYNA, a cannabinoid-enhanced clean skincare company, announces the debut of three new research-driven topical formulations, featuring a patent-pending GALYNA molecule that ...
Patient-centric drug development enhances adherence and treatment outcomes by incorporating patient input into the process, supported by FDA guidance. CDMOs have become strategic partners, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results